Novartis AG Other Operating Income or Expenses 2010-2024 | NVS
Novartis AG other operating income or expenses for the twelve months ending June 30, 2024 were $-0.975B, a 32.29% decline year-over-year.
- Novartis AG annual other operating income or expenses for 2023 were $-0.531B, a 79.32% decline from 2022.
- Novartis AG annual other operating income or expenses for 2022 were $-2.568B, a 186.93% increase from 2021.
- Novartis AG annual other operating income or expenses for 2021 were $-0.895B, a 38.19% decline from 2020.